INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 431m ago
HOUSE PTR30m ago
SEC 13F30m ago
ROBINHOOD CHAIN30m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Quartel Adrian W sold ZVRA

Chief Medical Officer · ZEVRA THERAPEUTICS, INC. · Common Stock

Side
SELL
Value
$40K
Shares
4,533
Price
$8.83
Executed
Jan 30, 2026
Disclosed
Feb 2, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jan 30 executedFeb 2, 2026 disclosed

ZVRA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
18/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+9 / 25

    $40K reported value · 31.8% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ZVRA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$97K
    10.5K sh
    		Feb 3, 2026Feb 4, 2026
    traded Feb 3, 2026
    		+1dSEC FORM 4

    Evidence

    7
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    11.3K sh
    		Jan 30, 2026Feb 2, 2026
    traded Jan 30, 2026
    		+3dSEC FORM 4

    Evidence

    14
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$30K
    3,375 sh
    		Jan 30, 2026Feb 2, 2026
    traded Jan 30, 2026
    		+3dSEC FORM 4

    Evidence

    7
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    35.3K sh
    		Jan 31, 2026Feb 2, 2026
    traded Jan 31, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Grant or award · 10b5-1 plan
    		A—
    37.5K sh
    		Jan 29, 2026Feb 2, 2026
    traded Jan 29, 2026
    		+4dSEC FORM 4

    Evidence

    0
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Grant or award · 10b5-1 plan
    		A—
    75.0K sh
    		Jan 29, 2026Feb 2, 2026
    traded Jan 29, 2026
    		+4dSEC FORM 4

    Evidence

    11
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    11.3K sh
    		Jan 30, 2026Feb 2, 2026
    traded Jan 30, 2026
    		+3dSEC FORM 4

    Evidence

    11
    QW
    Quartel Adrian WChief Medical Officer
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    11.3K sh
    		Jan 30, 2026Feb 2, 2026
    traded Jan 30, 2026
    		+3dSEC FORM 4

    Evidence

    0
    QW
    Quartel Adrian WChief Medical Officer
    ZVRAZEVRA THERAPEUTICS, INC.
    Grant or award · 10b5-1 plan
    		A—
    37.5K sh
    		Jan 29, 2026Feb 2, 2026
    traded Jan 29, 2026
    		+4dSEC FORM 4

    Evidence

    0
    QW
    Quartel Adrian WChief Medical Officer
    ZVRAZEVRA THERAPEUTICS, INC.
    Grant or award · 10b5-1 plan
    		A—
    75.0K sh
    		Jan 29, 2026Feb 2, 2026
    traded Jan 29, 2026
    		+4dSEC FORM 4

    Evidence

    11
    QW
    Quartel Adrian WChief Medical Officer
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    11.3K sh
    		Jan 30, 2026Feb 2, 2026
    traded Jan 30, 2026
    		+3dSEC FORM 4

    Evidence

    0
    SJ
    Schafer JoshuaCCO
    ZVRAZEVRA THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    35.3K sh
    		Jan 31, 2026Feb 2, 2026
    traded Jan 31, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001910132-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 30, 2026
    Published
    Feb 2, 2026
    Ingested by INSIDER
    Nov 5, 04:19 UTC
    Last re-read
    Nov 5, 04:19 UTC

    Extracted facts

    Filer
    Quartel Adrian W
    Role
    Chief Medical Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    ZEVRA THERAPEUTICS, INC.
    Ticker
    ZVRA
    Shares
    4,533
    Price per share
    $8.83
    Value
    $40,036
    Execution date (reported)
    Jan 30, 2026
    Owned after transaction
    9,723 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    3

    Calculation

    Value = shares × reported price per share

    • Shares: 4,533
    • Price: $8.8321

    = $40,036

    What this establishes

    Quartel Adrian W filed this Form 4 reporting a open-market sale of ZVRA on Jan 30, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Quartel Adrian Wcik:0001910132
    Issuer
    ZEVRA THERAPEUTICS, INC.cik:0001434647

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.